CD34+ fibrocytes are preserved in most invasive lobular carcinomas of the breast

Pathology Research and Practice

Volumn 203, Issue 9, 2007, Pages 695-698

  Ebrahimsade, Schokufe ^a,b   Westhoff, Christina C ^a,b   Barth, Peter J ^a,b  

^a UNIVERSITY HOSPITAL MARBURG   (Germany)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Breast; Carcinoma; CD34; Invasive lobular carcinoma; Stroma

Indexed keywords

CD34 ANTIGEN;

ADULT; AGED; ANTIGEN DETECTION; ANTIGEN EXPRESSION; ARTICLE; BREAST CARCINOMA; CANCER INVASION; CELL LOSS; CELL POPULATION; CLINICAL ARTICLE; DIAGNOSTIC VALUE; DISEASE MARKER; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; STROMA CELL; TISSUE STRUCTURE;

EID: 34548127981     PISSN: 03440338     EISSN: 16180631     Source Type: Journal    
DOI: 10.1016/j.prp.2007.05.009     Document Type: Article

References (13)

1. + fibrocytes in invasive ductal carcinoma, ductal carcinoma in situ, and benign breast lesions. Virchows Arch. 440 (2002) 298-303
2. + fibrocytes in neoplastic and inflammatory pancreatic lesions. Virchows Arch. 440 (2002) 128-133
3. + fibrocytes in normal cervical stroma, cervical intraepithelial neoplasia III, and invasive squamous cell carcinoma of the cervix uteri. Virchows Arch. 441 (2002) 564-568
4. + fibrocytes, α-smooth muscle antigen-positive myofibroblasts, and CD117 expression in the stroma of invasive squamous cell carcinomas of the oral cavity, pharynx, and larynx. Virchows Arch. 444 (2004) 231-234
5. Barth P.J., Moll R., and Ramaswamy A. Stromal remodeling and SPARC (secreted protein acid rich in cysteine) expression in invasive ductal carcinomas of the breast. Virchows Arch. 446 (2005) 532-536
6. Chauhan H., Abraham A., Phillips J.R., Pringle J.H., Walker R.A., and Jones J.L. There is more than one kind of myofibroblast: analysis of CD34 expression in benign, in situ, and invasive breast lesions. J. Clin. Pathol. 56 (2003) 271-276
7. Kuroda N., Sugimoto T., Takahashi T., Moriki T., Toi M., Miyazaki E., Hiroi M., and Enzan H. Invasive micropapillary carcinoma of the breast: an immunohistochemical study of neoplastic and stromal cells. Int. J. Surg. Pathol. 13 (2005) 51-55
8. Kuroda N., Jin Y.L., Hamauzu T., Toi M., Miyazaki E., Hiroi M., Moriki T., and Enzan H. Consistent lack of CD34-positive stromal cells in the stroma of malignant breast lesions. Histol. Histopathol. 20 (2005) 707-712
9. Nakayama H., Enzan H., Miyazaki E., Kuroda N., Naruse K., and Hiroi M. Differential expression of CD34 in normal colorectal tissue, peritumoral inflammatory tissue, and tumour stroma. J. Clin. Pathol. 53 (2000) 626-629
10. Nakayama H., Enzan H., Miyazaki E., Kuroda N., Naruse K., Kiyoku H., Toi M., and Hiroi M. CD34 positive stromal cells in gastric adenocarcinomas. J. Clin. Pathol. 54 (2001) 846-848
11. Nakayama H., Enzan H., Yamamoto M., Miyazaki E., Hidaka C., Okumichi T., Okumichi A., and Kajihara H. CD34-positive stromal cells in primary lung carcinomas. Oncol. Rep. 10 (2003) 1313-1316
12. + fibrocytes in tubular carcinomas and radial scars of the breast. Virchows Arch. 443 (2003) 536-540
13. Yazhou C., Wenlv S., Weidong Z., and Licun W. Clinicopathological significance of stromal myofibroblasts in invasive ductal carcinoma of the breast. Tumour Biol. 25 (2004) 290-295